Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Unfolded Protein Response (UPR) is a complex intracellular signaling network activated by endoplasmic reticulum (ER) stress, a condition where misfolded proteins accumulate in the ER lumen. In the context of oncology, tumor cells frequently encounter ER stress due to intrinsic factors like oncogene activation and extrinsic factors such as hypoxia and nutrient scarcity. The UPR initially serves a cytoprotective role by enhancing protein folding capacity and reducing translation, thereby promoting tumor cell survival, metastasis, and chemoresistance. However, if ER stress is severe or persistent, the UPR can transition from a pro-survival to a pro-apoptotic program, primarily through the induction of CHOP. Therapeutic interventions target key UPR sensors—IRE1α, PERK, and ATF6—to either disrupt survival signaling or push cells toward terminal apoptosis, offering a strategy to overcome drug resistance and improve patient outcomes.
Modulation of ER stress sensors (IRE1α, PERK, ATF6) and chaperones (GRP78/BiP) to either inhibit pro-survival signaling or exacerbate stress to trigger terminal apoptosis in tumor cells.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum stress and unfolded protein response pathway (UPR).